GoodRx Expects Q4 FY23 Adjusted Revenue Of $188M-$194M Vs. Consensus Of $192.67M
Portfolio Pulse from Benzinga Newsdesk
GoodRx has projected its Q4 FY23 adjusted revenue to be between $188M and $194M, which is in line with the consensus estimate of $192.67M.
November 09, 2023 | 11:05 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
GoodRx's Q4 FY23 adjusted revenue forecast is in line with market expectations, which could maintain investor confidence.
GoodRx's projected revenue for Q4 FY23 falls within the range of the consensus estimate. This alignment with market expectations could help maintain investor confidence in the company, potentially keeping the stock price stable in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100